- Home
- YOU vs KNSA Comparison
YOU vs KNSA Comparison
Compare YOU & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- KNSA
- Stock Information
- Founded
- YOU 2010
- KNSA 2015
- Country
- YOU United States
- KNSA United Kingdom
- Employees
- YOU N/A
- KNSA N/A
- Industry
- YOU Computer Software: Prepackaged Software
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- YOU Technology
- KNSA Health Care
- Exchange
- YOU Nasdaq
- KNSA Nasdaq
- Market Cap
- YOU 2.3B
- KNSA 2.1B
- IPO Year
- YOU 2021
- KNSA 2018
- Fundamental
- Price
- YOU $28.06
- KNSA $27.13
- Analyst Decision
- YOU Strong Buy
- KNSA Strong Buy
- Analyst Count
- YOU 4
- KNSA 5
- Target Price
- YOU $33.50
- KNSA $38.80
- AVG Volume (30 Days)
- YOU 1.6M
- KNSA 1.1M
- Earning Date
- YOU 08-05-2025
- KNSA 07-22-2025
- Dividend Yield
- YOU 2.74%
- KNSA N/A
- EPS Growth
- YOU 182.03
- KNSA N/A
- EPS
- YOU 1.59
- KNSA N/A
- Revenue
- YOU $802,807,000.00
- KNSA $481,166,000.00
- Revenue This Year
- YOU $14.81
- KNSA $37.21
- Revenue Next Year
- YOU $10.46
- KNSA $5.32
- P/E Ratio
- YOU $17.64
- KNSA N/A
- Revenue Growth
- YOU 21.59
- KNSA 59.45
- 52 Week Low
- YOU $18.23
- KNSA $17.38
- 52 Week High
- YOU $38.88
- KNSA $30.69
- Technical
- Relative Strength Index (RSI)
- YOU 71.03
- KNSA 44.42
- Support Level
- YOU $27.23
- KNSA $27.08
- Resistance Level
- YOU $28.37
- KNSA $28.86
- Average True Range (ATR)
- YOU 0.81
- KNSA 1.04
- MACD
- YOU 0.29
- KNSA -0.32
- Stochastic Oscillator
- YOU 92.69
- KNSA 16.05
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.